These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 28427041)

  • 1. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.
    Atukeren P; Cengiz M; Yavuzer H; Gelisgen R; Altunoglu E; Oner S; Erdenen F; Yuceakın D; Derici H; Cakatay U; Uzun H
    Biomed Pharmacother; 2017 Jun; 90():786-795. PubMed ID: 28427041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.
    Bohnen NI; Kaufer DI; Hendrickson R; Ivanco LS; Lopresti BJ; Koeppe RA; Meltzer CC; Constantine G; Davis JG; Mathis CA; Dekosky ST; Moore RY
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):315-9. PubMed ID: 15716518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
    Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
    Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling donepezil template into multipotent hybrids with antioxidant properties.
    Mezeiova E; Spilovska K; Nepovimova E; Gorecki L; Soukup O; Dolezal R; Malinak D; Janockova J; Jun D; Kuca K; Korabecny J
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):583-606. PubMed ID: 29529892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease.
    Davidsson P; Blennow K; Andreasen N; Eriksson B; Minthon L; Hesse C
    Neurosci Lett; 2001 Mar; 300(3):157-60. PubMed ID: 11226635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system.
    Zivin M; Pregelj P
    Psychiatr Danub; 2008 Jun; 20(2):168-73. PubMed ID: 18587286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Wang ZM; Cai P; Liu QH; Xu DQ; Yang XL; Wu JJ; Kong LY; Wang XB
    Eur J Med Chem; 2016 Nov; 123():282-297. PubMed ID: 27484514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
    Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
    Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography.
    Ota T; Shinotoh H; Fukushi K; Kikuchi T; Sato K; Tanaka N; Shimada H; Hirano S; Miyoshi M; Arai H; Suhara T; Irie T
    Clin Neuropharmacol; 2010; 33(2):74-8. PubMed ID: 19935404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates.
    Piemontese L; Tomás D; Hiremathad A; Capriati V; Candeias E; Cardoso SM; Chaves S; Santos MA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1212-1224. PubMed ID: 30160188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does caffeine influence the anticholinesterase and antioxidant properties of donepezil? Evidence from in vitro and in vivo studies.
    Oboh G; Ogunsuyi OB; Olonisola OE
    Metab Brain Dis; 2017 Apr; 32(2):629-639. PubMed ID: 28091956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.
    Darreh-Shori T; Meurling L; Pettersson T; Hugosson K; Hellström-Lindahl E; Andreasen N; Minthon L; Nordberg A
    J Neural Transm (Vienna); 2006 Nov; 113(11):1791-801. PubMed ID: 16868793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donepezil hydrochloride: a treatment drug for Alzheimer's disease.
    Sugimoto H
    Chem Rec; 2001; 1(1):63-73. PubMed ID: 11893059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil: an important prototype to the design of new drug candidates for Alzheimer's disease.
    Rodrigues Simões MC; Dias Viegas FP; Moreira MS; de Freitas Silva M; Riquiel MM; da Rosa PM; Castelli MR; dos Santos MH; Soares MG; Viegas C
    Mini Rev Med Chem; 2014 Jan; 14(1):2-19. PubMed ID: 24251806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
    Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
    Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.